Epinephrine injection therapy versus a combination of epinephrine injection and endoscopic hemoclip in the treatment of bleeding ulcers.
OBJECTIVE
To assess the efficacy of hemoclip application in combination with epinephrine injection in the treatment of bleeding peptic ulcers and to compare the clinical outcomes between patients treated with such a combination therapy and those treated with epinephrine injection alone.


METHODS
A total of 293 patients (211 males, 82 females) underwent endoscopic therapy for bleeding peptic ulcers. Of these, 202 patients (152 males, 50 females) received epinephrine injection therapy while 91 patients (59 males, 32 females) received combination therapy. The choice of endoscopic therapy was made by the endoscopist. Hemostatic rates, rebleeding rates, need for emergency surgery and 30-d mortality were the outcome measures studied.


RESULTS
Patients who received combination therapy were significantly older (mean age 66+/-16 years, range 24-90 years) and more suffered from chronic renal failure compared to those who received epinephrine injection therapy alone (mean age 61+/-17 years, range 21-89 years). Failure to achieve permanent hemostasis was 4% in the group who received epinephrine injection alone and 11% in the group who received combination therapy. When the differences in age and renal function between the two treatment groups were taken into account by multivariate analysis, the rates of initial hemostasis, rebleeding rates, need for surgery and 30-d mortality for both treatment options were not significantly different.


CONCLUSIONS
Combination therapy of epinephrine injection with endoscopic hemoclip application is an effective method of achieving hemostasis in bleeding peptic ulcer diseases. However, superiority of combination therapy over epinephrine injection alone, could not be demonstrated.
Chua
Tju-Siang
TS
Changi General Hospital, 2 Simei Street 3, Singapore 529889, Republic of Singapore. tju_siang_chua@cgh.com.sg
Fock
Kwong-Ming
KM
Ng
Tay-Meng
TM
Teo
Eng-Kiong
EK
Tan
Jessica-Yi-Lyn
JY
Ang
Tiing-Leong
TL
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003131:Combined Modality Therapy; D016099:Endoscopy, Gastrointestinal; D004837:Epinephrine / Q000008:administration & dosage*; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D013525:Surgical Instruments; D016896:Treatment Outcome; D014662:Vasoconstrictor Agents / Q000008:administration & dosage*
D014662:Vasoconstrictor Agents; D004837:Epinephrine
World J Gastroenterol. 2000 Feb;6(1):53-56
11819522
Q J Med. 1976 Oct;45(180):533-50
1087420
Br J Surg. 1994 Jun;81(6):869-71
8044606
Gastroenterology. 1996 Sep;111(3):623-8
8780566
Br Med J. 1979 May 12;1(6173):1238-40
313232
Gastrointest Endosc. 1990 Sep-Oct;36(5 Suppl):S1-65
2242800
Br Med J. 1973 Jun 2;2(5865):505-9
4541367
Surg Endosc. 1988;2(1):13-7
3051463
JAMA. 1990 Jul 25;264(4):494-9
2142225
Surgery. 1986 Oct;100(4):765-73
3490003
Int Surg. 1995 Apr-Jun;80(2):134-7
8530229
Gut. 1999 May;44(5):715-9
10205211
Gastrointest Endosc. 1981 May;27(2):73-9
6971775
Mayo Clin Proc. 1988 Jun;63(6):596-604
3287023
Gastroenterology. 1992 Jan;102(1):139-48
1530782
Surg Laparosc Endosc. 1997 Apr;7(2):94-6
9109234
Br Med J. 1970 Apr 4;2(5700):7-14
5440587
Gut. 1994 May;35(5):608-10
8200551
Gastrointest Endosc. 1981 May;27(2):80-93
6971776
BMJ. 1997 May 3;314(7090):1307-11
9158465
Endoscopy. 1993 Feb;25(2):167-70
8491134
Gastrointest Endosc. 1996 Jun;43(6):591-5
8781939